Source: Global times https://www.globaltimes.cn/page/202112/1241338.shtml Accessed: 2021-12-20China's first domestic magnetically levitated artificial heart, developed by CH Biomedical in Suzhou, East China's Jiangsu Province, has been approved for commercial use, marking that the surgical treatment for heart failure in China has entered the era of artificial heart [...].
Hu Shengshou, president from Shenzhen-based Fuwai Hospital [...] said heart failure is the final stage of heart disease, and as China enters the ageing era, the prevalence of heart failure cases continues to increase.
At present, China has more than 10 million patients suffering from heart failure, with many requiring heart transplant surgery. However, the source of donor hearts is limited, and a significant number of patients pass away while waiting for a matching donor heart. As a result, artificial hearts are seen as a key breakthrough.
According to Hu, maglev hearts, which is smaller and more compatible, can reduce blood stagnation and thrombosis, significantly improving clinical outcomes.
Although China's artificial heart research emerged behind that of mature economies, it gained rapid progress. Since 2017, China has developed three types of artificial hearts, including the one from Shenzhen, which is the world's smallest and lightest maglev artificial heart.
1 post • Page 1 of 1
PR China: Maglev artificial heart approved for commercial use
Sometimes active on Twitter, but not regularly.